MiRNA profiling of the MV4-11 cell line treated with trabectidin or azacitidin

ABSTRACT: In order to study the effects of trabectedin in chronic myelomonocytic leukemia and in juvenile myelomonocytic leukemia, we performed whole genome transcriptional profiling of a model cell line treated under either the reference drug for CMML / JMML (Azacitidine) or trabectedin.

ORGANISM(S): Homo sapiens

SUBMITTER: Luca Beltrame 

PROVIDER: E-MTAB-2979 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress